Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates
2021 · iScience · 30 citations
https://doi.org/10.1016/j.isci.2021.102047
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
734
Citations
11
h-index
11
i10-index
Dai Fujikawa is an academic researcher from National Cancer Institute. The author has contributed to research in topics: T-cell and Retrovirus Studies & Vector-Borne Animal Diseases & HIV Research and Treatment. The author has an h-index of 11, co-authored 15 publications.
https://doi.org/10.1016/j.isci.2021.102047
https://doi.org/10.1186/1742-4690-11-s1-p144
Click to start Chat